Drug Type Small molecule drug |
Synonyms Asphanate, Aspirin/Dihydroxyaluminium Aminoacetate/Heavy Magnesium Carbonate, Bufferin + [17] |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (22 Sep 2000), |
Regulation- |
Molecular FormulaC12H16AlMgNO11 |
InChIKeyKBSUEWXOYXVBHN-UHFFFAOYSA-K |
CAS Registry53664-49-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Common Cold | JP | 19 Jun 2009 | |
Headache | JP | 19 Jun 2009 | |
Neuralgia | JP | 19 Jun 2009 | |
Rheumatic Fever | JP | 19 Jun 2009 | |
Rheumatoid Arthritis | JP | 19 Jun 2009 | |
Toothache | JP | 19 Jun 2009 | |
Mucocutaneous Lymph Node Syndrome | JP | 01 Oct 2005 | |
Angina Pectoris | JP | 01 Nov 2000 | |
Brain Ischemia | JP | 01 Nov 2000 | |
Myocardial Infarction | JP | 01 Nov 2000 | |
Thrombosis | JP | 01 Nov 2000 | |
Angina, Stable | JP | 22 Sep 2000 | |
Angina, Stable | JP | 22 Sep 2000 | |
Angina, Unstable | JP | 22 Sep 2000 | |
Angina, Unstable | JP | 22 Sep 2000 | |
Brain Infarction | JP | 22 Sep 2000 | |
Brain Infarction | JP | 22 Sep 2000 | |
Ischemic Attack, Transient | JP | 22 Sep 2000 | |
Ischemic Attack, Transient | JP | 22 Sep 2000 | |
Thromboembolism | JP | 22 Sep 2000 |